January 2023 Issue: Apellis Pharmaceuticals (SYM: APLS)
- Dylan Jovine
- Friday, January 13, 2023
An aging population is demanding better treatment in an effort to live longer lives (I'm beginning to count myself among that population).
As we've detailed in these pages over the years, there's incredible new innovation in gene therapies, immuno-oncology, precision medicine, machine-learning drug discovery, and treatments for unmet medical needs, such as Geographic Apathy.
November 2022 Issue: Nerdy Inc. (SYM: NRDY)
- Dylan Jovine
- Monday, November 21, 2022
Education is witnessing a massive, transformational shift. In fact, the online learning category is expected to grow more than five times over the next seven years, according to IPO Edge, which is more than two times faster that e-commerce growth between 2014 and 2019.
UPDATE: on Clovis and MEI Pharma
- Dylan Jovine
- Tuesday, October 4, 2022
Wanted to give you all a quick update on Clovis (SYM: CLVS) and MEI Pharma (SYM: MEIP). The iron rule of biotech investing is to bet on the science.
January 2023 Issue: Apellis Pharmaceuticals (SYM: APLS)
- Dylan Jovine
- Friday, January 13, 2023
An aging population is demanding better treatment in an effort to live longer lives (I'm beginning to count myself among that population).
As we've detailed in these pages over the years, there's incredible new innovation in gene therapies, immuno-oncology, precision medicine, machine-learning drug discovery, and treatments for unmet medical needs, such as Geographic Apathy.
November 2022 Issue: Nerdy Inc. (SYM: NRDY)
- Dylan Jovine
- Monday, November 21, 2022
Education is witnessing a massive, transformational shift. In fact, the online learning category is expected to grow more than five times over the next seven years, according to IPO Edge, which is more than two times faster that e-commerce growth between 2014 and 2019.
UPDATE: on Clovis and MEI Pharma
- Dylan Jovine
- Tuesday, October 4, 2022
Wanted to give you all a quick update on Clovis (SYM: CLVS) and MEI Pharma (SYM: MEIP). The iron rule of biotech investing is to bet on the science.
Categories
Recent posts
Tags
Connect with Us
Get FREE Weekly Stock Tips
Join and receive market insider stock picks, trade alerts and unique investing insights
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.
